The New Republic: Why Avastin Repeal Isn’t Harmful

Last month, the FDA withdrew approval for the drug Avastin to be used for breast cancer treatment, a decision that had conservative critics in an uproar. But Jonathan Cohn of The New Republic argues that it was a good decision, and that the FDA has been rejecting drugs long before Obama?s health reform.

Jennifer Morrison Jennifer ODell Jennifer Scholle Microsoft